Press releases

KANE BIOTECH ANNOUNCES INCREASE TO PRIVATE PLACEMENT OFFERING

WINNIPEG, Manitoba (May 26, 2006) - Kane Biotech Inc. (TSX-V:KNE) (the "Company"), a leading biofilm company, today announces an increase in the size of its previously announced private placement offering (the "Offering") of up to 2,181,818 units ("Units") at a price of $0.55 per Unit for gross proceeds of up to $1,200,000. Due to strong demand for the Offering, the Company has determined to increase the size of the Offering to 2,727,273 Units at a price of $0.55 per Unit for gross proceeds of up to $1,500,000. Each Unit will still be comprised of one common share of the Company (a "Share") and one half of one Share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to purchase one Share at a price of $0.70 per Share for a period of 18 months from the date of issuance of the Warrant. All other terms of the Offering remain the same.

The Offering is subject to receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

About Kane Biotech Inc.
Kane Biotech is a biotechnology company engaged in the development of products to prevent and disperse bacterial biofilms. Biofilms develop when bacteria, and other microorganisms, form a protective matrix that acts as a shield against attack. When in a biofilm, bacteria become highly resistant to antibiotics, high temperatures and host immune responses. This resiliency contributes to human health problems such as recurrent urinary tract infections, medical device associated infections and tooth decay.

For more information, please contact: